ANTH - Anthera Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ANTH (1316175)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
6 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S3-1+3-11-40

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-09-20
ANTHThompson John CraigPres, CEOP - Purchase$1.32+8,55019,848+76%+$11,286
2017-09-07
ANTHTruex Paul FDirP - Purchase$1.34+5,00016,793+42%+$6,700
A
2017-09-07
ANTHThompson John CraigPres, CEOP - Purchase$1.43+10,40011,298>999%+$14,893
D
2015-11-13
ANTHHislop ColinChief Medical OfficerS - Sale+OE$5.31-12,50021,044-37%-$66,341-4-7-9-42
2015-11-11
ANTHHislop ColinChief Medical OfficerS - Sale$5.38-5,00021,044-19%-$26,900+3+8-12-38
2015-10-12
ANTHOdink DebraCTOS - Sale$6.15-1,20521,751-5%-$7,411-2+7-12-40

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top